Clinical Trial Detail

NCT ID NCT01438112
Title Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer (BOND)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors CG Oncology, Inc.
Indications

bladder urothelial carcinoma

Therapies

Valrubicin

Mitomycin C

CG0070

Interferon gamma

Gemcitabine

Age Groups: senior adult

No variant requirements are available.